Table 5.
Biological sample | miRNA profiling | Subjects | Phenotype | Main findings | PMID [reference] |
---|---|---|---|---|---|
| |||||
Whole blood | Human MicroRNA v2.0 Assay Pool (Illumina). | Children with (n=100) and without asthma (n=100) recruited at a Turkish hospital | Asthma severity (GINA, 2008) and AEs severity | Increased expression of 10 miRNAs was associated with asthma severity and exacerbations severity: HS_108.1, HS_112, HS_182.1, HS_240, HS_261.1, HS_3, HS_55.1, HS_91.1, hsa-mir-604, and hsa-mir-638. | 26422695 [104] |
| |||||
Peripheral blood | q-PCR | Children with acute-stage asthma (n=100) and healthy children (n=100) recruited at a Chinese hospital | Acute asthma attacks (not defined) | miR-1 expression levels were reduced in acute-stage asthma compared with controls. miR-1 expression levels improved prediction of acute asthma attacks compared with IL-4, IL-5, IL-8, and TNF-α in the same population. |
30046607 [105] |
| |||||
Serum | q-PCR | Subjects with (n=59) and without asthma (n=11) recruited in the United States | Lifetime and past 12 months frequency of asthma-related hospitalizations | miR-1 levels were inversely correlated with sputum eosinophilia and asthma-related hospitalization frequency, and positively correlated with lung function and ACT scores. | 32035607 [106] |
| |||||
Serum | q-PCR | European children with asthma from CAMP: 38 with and 115 without exacerbations | OCS bursts in the past 12 months following randomization with ICS | Increased expression of 12 miRNAs was associated with OCS bursts: miR-206, miR-146b-5p, miR-222–3p, miR-409–3p, miR-223–5p, miR-126–5p, miR-339–3p, miR-30e-3p, miR-126–3p, miR-342–3p, miR-454–3p, and miR-720. A clinical and 3-miRNA model (miR-146b, miR-206, and miR-720) showed higher AUC for prediction of OCS use compared with the clinical model in the same population (AUC: 0.81 vs 0.67). |
29940952 [107] |
| |||||
Serum | q-PCR | 6-week longitudinal study of 21 adults with asthma recruited at a Polish hospital | Admission for an unplanned visit due to worsened symptoms of asthma accompanied by a decrease in ventilatory parameters | Reduced levels of miRNA-126a, miRNA-16, and miRNA-21 during the exacerbation compared with the follow-up visit. | 31743969 [108] |
| |||||
Induced sputum | Nanostring nCounter array v3.0a | Subjects with (n=62) and without asthma (n=9) recruited in the United States | Asthma-related hospitalizations in the past 12 months | A 12 miRNA.WGCNA module was directly correlated with asthma hospitalizations. Ten of these miRNA correlated significantly and consistently with sputum neutrophils, longer duration of asthma, decreased quality of life, impaired lung function, and/or increased BDR. The miRNA module correlated with a mRNA module enriched in genes participating in TLR/Th17 signalling and endoplasmic reticulum stress. | 32255668 [109] |
| |||||
Whole blood | Small-RNA sequencing | Costa Rican children with asthma (nFE=183; nIF=168) from GARCS | ≥3 events of asthma-related ER/AC visits and/or hospitalizations in the last 12 months (frequent exacerbations, FE) compared with no or infrequent exacerbation (IF) | 5 miRNA (miR-451b, hsa-miR-142–5p, hsa-miR-6739–3p, hsa-miR-7–5p, and hsa-miR-4433b-5p) were downregulated in FE compared with IF. 15 mIRNA (hsa-miR-93–3p, hsa-miR-766–3p, hsa-miR-331–3p, hsa-miR-532–3p, hsa-miR-664b-3p, hsa-miR-296–5p, hsa-miR-6515–3p, hsa-miR-4286, hsa-miR-1296–5p, hsa-miR-29b-2–5p, hsa-miR-500b-5p, hsa-miR-500a-5p, hsa-miR-642a-5p, hsa-miR-103a-2–5p, and hsa-miR-550a-3p) were upregulated in FE compared with IF. miR-532–3p, miR-296–5p, miR-766–3p, miR-7–5p, and miR-451b also showed significant association with COPD exacerbations. |
35447890 [110] |
Abbreviations: AC: Acute care; AUC: Area under the curve; CAMP: Childhood Asthma Management Program; COPD: Chronic obstructive pulmonary disease; ER: Emergency room; FE: Frequent exacerbations; GARCS: Genetics of Asthma in Costa Rica Study; GINA: Global Initiative for Asthma; ICS: Inhaled corticosteroids; IF: No or infrequent exacerbations; mRNA: Messenger RNA; OCS: Oral corticosteroids; q-PCR: Real-time quantitative polymerase chain reaction; RNA: Ribonucleic acid; Th17: T helper 17 cells; TLR: Toll-like receptor; WGCNA: Weighted gene co-expression network analysis.